Home › Sickle Cell Disease

Sickle Cell Disease clinical trials recruiting in the U.S.

106 studies for Sickle Cell Disease are recruiting participants at sites across the United States.

Sickle cell disease is a group of inherited disorders that affect your red blood cells. It can cause pain, anemia, and other problems. Learn about treatments.

Cities with the most studies

• Washington, DC21 studies
• Atlanta, GA20 studies
• Memphis, TN19 studies
• Chicago, IL18 studies
• New York City, NY16 studies
• Philadelphia, PA15 studies
• Birmingham, AL14 studies
• Houston, TX12 studies
• Boston, MA12 studies
• St. Louis, MO12 studies
• Durham, NC10 studies
• Cincinnati, OH10 studies
• Greenville, NC9 studies
• Columbus, OH9 studies
• Pittsburgh, PA9 studies
• Los Angeles, CA8 studies
• The Bronx, NY8 studies
• Baltimore, MD7 studies
• Charlotte, NC7 studies
• Cleveland, OH7 studies
• Oakland, CA7 studies
• Augusta, GA5 studies
• Detroit, MI5 studies
• Hartford, CT5 studies
• Jackson, MS5 studies
• Richmond, VA5 studies
• Phoenix, AZ5 studies
• Indianapolis, IN5 studies
• Nashville, TN5 studies
• Milwaukee, WI4 studies
• New Orleans, LA4 studies
• New Haven, CT4 studies
• Arlington, VA4 studies
• Greenville, SC4 studies
• Queens, NY4 studies
• Minneapolis, MN4 studies
• Greenburgh, NY3 studies
• Edison, NJ3 studies
• Mobile, AL3 studies
• Rochester, NY3 studies

By state

• Alabama16 studies
• Arizona5 studies
• Arkansas3 studies
• California19 studies
• Connecticut7 studies
• Delaware6 studies
• District of Columbia11 studies
• Florida9 studies
• Georgia23 studies
• Illinois19 studies
• Indiana5 studies
• Louisiana5 studies
• Maryland17 studies
• Massachusetts12 studies
• Michigan9 studies
• Minnesota6 studies
• Mississippi5 studies
• Missouri13 studies
• New Jersey8 studies
• New York23 studies
• North Carolina18 studies
• Ohio22 studies
• Pennsylvania20 studies
• South Carolina6 studies
• Tennessee22 studies
• Texas13 studies
• Virginia8 studies
• Wisconsin4 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.